Search results
- (-) Remove Basic page filter Basic page
Adeno-Associated Virus (AAV) platform
Our experienced team of end-to-end AAV experts strive to accelerate progress in the AAV industry to further our mission to improve patients
All platforms
Oxford Biomedica is a global cell and gene therapy company with capabilities across key viral vector types and a focus on
Adenovirus expertise
Building on its world leading position in lentiviral vectors, Oxford Biomedica has demonstrated the versatility of its platform by undertak